References
- Winer A, Adams S, Mignatti P. Matrix metalloproteinase inhibitors in cancer therapy: Turning past failures into future successes. Mol Cancer Ther. 2018;17:1147-55. https://doi.org/10.1158/1535-7163.MCT-17-0646
- Brown GT, Murray GI. Current mechanistic insights into the roles of matrix metalloproteinases in tumour invasion and metastasis. J Pathol. 2015;237:273-81. https://doi.org/10.1002/path.4586
- Liu HY, Gu WJ, Wang CZ, Ji XJ, Mu YM. Matrix metalloproteinase-9 and -2 and tissue inhibitor of matrix metalloproteinase-2 in invasive pituitary adenomas: A systematic review and meta-analysis of case-control trials. Medicine (Baltimore). 2016;95:e3904. https://doi.org/10.1097/MD.0000000000003904
- Rudek MA, Venitz J, Figg WD. Matrix metalloproteinase inhibitors: do they have a place in anticancer therapy? Pharmacotherapy. 2002; 22:705-20. https://doi.org/10.1592/phco.22.9.705.34062
- Jablonska-Trypuc A, Matejczyk M, Rosochacki S. Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs. J Enzyme Inhib Med Chem. 2016; 31:177-83. https://doi.org/10.3109/14756366.2016.1161620
- Kessenbrock K, Wang CY, Werb Z. Matrix metalloproteinases in stem cell regulation and cancer. Matrix Biol. 2015;44-46:184-90. https://doi.org/10.1016/j.matbio.2015.01.022
- Shim SH, Kim JH, Choi JH, Jeong HW. Influences on the anticancer and inhibitive effects of the secondary effects by anticarcinogen of Shibyukmiyouki-Eum. J Orient Med Surg Ophthalmol Otolaryngol. 2002;15:302-14.
- Lee MH, Lee JW, Park C, Han MH, Hong SH, Choi YH. Antioxidant, antimicrobial and anticancer properties of seven traditional herb-combined remedies. J Life Sci. 2015; 25:406-15. https://doi.org/10.5352/JLS.2015.25.4.406
- Choi EO, Son DH, Kim MY, Hwang-Bo H, Kim HJ, Jeong JW, Hong SH, Park C, Choi YH. Antioxidant and antimicrobial activities of herb-combined remedies used in traditional Korean medicine for treating breast cancer. J Life Sci. 2016;26:680-8. https://doi.org/10.5352/JLS.2016.26.6.680
- Yi J, Kim B. Effects of Sipyukmiyukieum on DNA synthesis, cAMP synthesis and MHC-class II expression of FRTL-5 thyroid cells. Korean J Orient Int Med. 2005;26:398-408.
- Kim MY, Bo HH, Choi EO, Kwon DH, Kim HJ, Ahn KI, Ji SY, Jeong JW, Park SH, Hong SH, Kim GY, Park C, Kim HS, Moon SK, Yun SJ, Kim WJ, Choi YH. Induction of apoptosis by Citrus unshiu Peel in human breast cancer MCF-7 cells: Involvement of ROS-dependent activation of AMPK. Biol Pharm Bull. 2018; 41:713-21. https://doi.org/10.1248/bpb.b17-00898
- Kim MY, Choi EO, HwangBo H, Kwon DH, Ahn KI, Kim HJ, Ji SY, Hong SH, Jeong JW, Kim GY, Park C, Choi YH. Reactive oxygen species-dependent apoptosis induction by water extract of Citrus unshiu peel in MDA-MB-231 human breast carcinoma cells. Nutr Res Pract. 2018;12:129-34. https://doi.org/10.4162/nrp.2018.12.2.129
- Ahn KI, Choi EO, Kwon DH, HwangBo H, Kim MY, Kim HJ, Ji SY, Hong SH, Jeong JW, Park C, Kim ND, Kim WJ, Choi YH. Induction of apoptosis by ethanol extract of Citrus unshiu Markovich peel in human bladder cancer T24 cells through ROS-mediated inactivation of the PI3K/Akt pathway. Biosci Trends. 2017;11:565-73. https://doi.org/10.5582/bst.2017.01218
- Lee S, Ra J, Song JY, Gwak C, Kwon HJ, Yim SV, Hong SP, Kim J, Lee KH, Cho JJ, Park YS, Park CS, Ahn HJ. Extracts from Citrus unshiu promote immune-mediated inhibition of tumor growth in a murine renal cell carcinoma model. J Ethnopharmacol. 2011; 133:973-9. https://doi.org/10.1016/j.jep.2010.07.018
- Kim A, Im M, Gu MJ, Ma JY. Citrus unshiu peel extract alleviates cancer-induced weight loss in mice bearing CT-26 adenocarcinoma. Sci Rep. 2016;6:24214. https://doi.org/10.1038/srep24214
- Kang BH, Jung WS, Kim SB, Yoo SK. Effects of Chungganhaewooltang on serum levels of histamine and corticosterone and immune response after immobilization-stress or coldstress in mice. J Orient Obstet Gynecol. 2005;18:85-105.
- Lee SH, Park CK. Anti-inflammatory effects of Ji-Pae-San water extract. Korean J Orient Med Prescription. 2008;16:79-94.
- Hwang KM. Anti-leukemic effects of JIPAESAN and its components on leukemic cells HL-60. Korean J Orient Med Prescription 2002;10; 143-155.
- Heo SJ, Hwang DS, Lee JM, Lee CH, Lee KS, Jang JB. Antimetastatic effects of Jipae-san by inflammation control and activation of innate immune system. J Korean Obstet Gynecol. 2014; 27:1-14.
- Zhang Y, Chen Q. Relationship between matrix metalloproteinases and the occurrence and development of ovarian cancer. Braz J Med Biol Res. 2017;50:e6104.
- Chaudhary AK, Pandya S, Ghosh K, Nadkarni A. Matrix metalloproteinase and its drug targets therapy in solid and hematological malignancies: an overview. Mutat Res. 2013; 753:7-23. https://doi.org/10.1016/j.mrrev.2013.01.002
- Sampieri CL, Leon-Cordoba K, Remes-Troche JM. Matrix metalloproteinases and their tissue inhibitors in gastric cancer as molecular markers. J Cancer Res Ther. 2013;9:356-63. https://doi.org/10.4103/0973-1482.119302
- Grzelczyk WL, Szemraj J, Jozefowicz-Korczynska M. The matrix metalloproteinase in larynx cancer. Postepy Hig Med Dosw (Online). 2016;70:1190-7.